Suppr超能文献

ATP敏感性钾通道1型磺脲类受体亚基在心肌缺血/再灌注损伤中的作用

Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.

作者信息

Elrod John W, Harrell Maddison, Flagg Thomas P, Gundewar Susheel, Magnuson Mark A, Nichols Colin G, Coetzee William A, Lefer David J

机构信息

Department of Medicine and Pathology, Albert Einstein College of Medicine, New York, NY, USA.

出版信息

Circulation. 2008 Mar 18;117(11):1405-13. doi: 10.1161/CIRCULATIONAHA.107.745539. Epub 2008 Mar 3.

Abstract

BACKGROUND

Opening of cardiac ATP-sensitive potassium channels (K(ATP) channels) is a well-characterized protective mechanism against ischemia and reperfusion injury. Evidence exists for an involvement of both sarcolemmal and mitochondrial K(ATP) channels in such protection. Classically, cardiac sarcolemmal K(ATP) channels are thought to be composed of Kir6.2 (inward-rectifier potassium channel 6.2) and SUR2A (sulfonylurea receptor type 2A) subunits; however, the evidence is strong that SUR1 (sulfonylurea receptor type 1) subunits are also expressed in the heart and that they may have a functional role. The aim of this study, therefore, was to examine the role of SUR1 in myocardial infarction.

METHODS AND RESULTS

We subjected mice lacking SUR1 subunits to in vivo myocardial ischemia/reperfusion injury. Interestingly, the SUR1-null mice were markedly protected against the ischemic insult, displaying a reduced infarct size and preservation of left ventricular function, which suggests a role for this K(ATP) channel subunit in cardiovascular function during conditions of stress.

CONCLUSIONS

SUR1 subunits have a high sensitivity toward many sulfonylureas and certain K(ATP) channel-opening drugs. Their potential role during ischemic events should therefore be considered both in the interpretation of experimental data with pharmacological agents and in the clinical arena when the cardiovascular outcome of patients treated with antidiabetic sulfonylureas is being considered.

摘要

背景

心脏ATP敏感性钾通道(K(ATP)通道)的开放是一种已被充分认识的针对缺血和再灌注损伤的保护机制。有证据表明肌膜和线粒体K(ATP)通道均参与了这种保护作用。传统上,心脏肌膜K(ATP)通道被认为由Kir6.2(内向整流钾通道6.2)和SUR2A(2A型磺脲类受体)亚基组成;然而,有充分证据表明SUR1(1型磺脲类受体)亚基也在心脏中表达,并且可能具有功能作用。因此,本研究的目的是探讨SUR1在心肌梗死中的作用。

方法与结果

我们使缺乏SUR1亚基的小鼠遭受体内心肌缺血/再灌注损伤。有趣的是,SUR1基因敲除小鼠对缺血损伤具有显著的保护作用,梗死面积减小,左心室功能得以保留,这表明该K(ATP)通道亚基在应激状态下的心血管功能中发挥作用。

结论

SUR1亚基对许多磺脲类药物和某些K(ATP)通道开放药物具有高度敏感性。因此,在解释使用药物制剂的实验数据以及考虑接受抗糖尿病磺脲类药物治疗患者的心血管结局时的临床领域,都应考虑它们在缺血事件中的潜在作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验